Compositions of Microbiota and Methods Related Thereto
Abstract
Methods and compositions are provided for treating weight related conditions and metabolic disorders by altering microbiota in a subject. One aspect provides methods and compositions to alter microbiota in a subject by administering to the subject a composition that includes a substantially purified microbiota from phyla such as Bacteroidetes, Proteobacteria, Firmicutes and Verrucomicrobia or orders such as Bacteroidales, Verrucomicrobiales, Clostridiales and Enterobacteriales or genera such as Alistipes, Clostridium, Escherichia , and Akkermansia . Another aspect includes a pharmaceutical composition for altering microbiota that includes a therapeutically effective amount of substantially purified microbiota and a pharmaceutically acceptable carrier. Yet another aspect includes methods for treating a disorder, such as obesity, in a subject in need of such treatment by changing relative abundance of microbiota in a gastrointestinal tract of the subject without or in addition to a surgical procedure.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for treating a metabolic disorder in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of bacteria, wherein the bacteria consist essentially of viable Akkermansia , and wherein said metabolic disorder is selected from the group consisting of obesity, insulin-deficiency related disorders, and insulin-resistance related disorders.
2 . The method according to claim 1 , wherein said metabolic disorder is obesity.
3 . The method according to claim 1 , wherein said Akkermansia is orally administered.
4 . The method according to claim 1 , wherein said Akkermansia is administered one or more times.
5 . The method according to claim 1 , wherein said Akkermansia is co-administered with one or more prebiotics.
6 . A method for increasing energy expenditure or for promoting weight loss in a subject, comprising administering Akkermansia to the subject.
7 . The method according to claim 6 , wherein viable cells of Akkermansia are administered to the subject in need thereof.
8 . The method according to claim 6 , wherein said Akkermansia is orally administered.
9 . The method according to claim 6 , wherein said Akkermansia is administered one or more times.
10 . The method according to claim 6 , wherein said Akkermansia is co-administered with another probiotic strain and/or with one or more prebiotics.
11 . A dietary supplement comprising Akkermansia.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.